CIN85 is required for Cbl-mediated regulation of antigen receptor signaling in human B cells

Blood

Volumn 119, Issue 10, 2012, Pages 2263-2273

  Niiro, Hiroaki ^a   Jabbarzadeh Tabrizi, Siamak ^a   Kikushige, Yoshikane ^b   Shima, Takahiro ^a   Noda, Kumiko ^a   Ota, Shun Ichiro ^a   Tsuzuki, Hirofumi ^a   Inoue, Yasushi ^a   Arinobu, Yojiro ^b   Iwasaki, Hiromi ^b   Shimoda, Shinji ^a   Baba, Eishi ^a   Tsukamoto, Hiroshi ^a   Horiuchi, Takahiko ^a   Taniyama, Tadayoshi ^c   Akashi, Koichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; C CBL INTERACTING PROTEIN OF 85 KDA; CBL PROTEIN; CD69 ANTIGEN; COMPLEMENTARY DNA; CYCLIN D2; GENOMIC DNA; LYMPHOCYTE ANTIGEN RECEPTOR; MYC PROTEIN; PHOSPHOLIPASE C GAMMA2; PROTEIN BCL X; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; RNA 18S; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UBIQUITINATION; WESTERN BLOTTING;

EID: 84858022572     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-351965     Document Type: Article

References (44)

1. Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2(12):945-956. (Pubitemid 37323215)
2. Kurosaki T, Shinohara H, Baba Y. B cell signaling and fate decision. Annu Rev Immunol. 2010;28: 21-55.
3. Pogue SL, Kurosaki T, Bolen J, Herbst R. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J Immunol. 2000;165(3):1300-1306. (Pubitemid 30604558)
4. Thien CB, Langdon WY. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem J. 2005; 391(pt 2):153-166. (Pubitemid 41532411)
5. Liu YC, Gu H. Cbl and Cbl-b in T-cell regulation. Trends Immunol. 2002;23(3):140-143. (Pubitemid 34178296)
6. Swaminathan G, Tsygankov AY. The Cbl family proteins: ring leaders in regulation of cell signaling. J Cell Physiol. 2006;209(1):21-43. (Pubitemid 44318665)
7. Duan L, Reddi AL, Ghosh A, Dimri M, Band H. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity. 2004;21(1):7-17. (Pubitemid 38925263)
8. Panchamoorthy G, Fukazawa T, Miyake S, et al. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1996;271(6):3187-3194.
9. Yasuda T, Maeda A, Kurosaki M, et al. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-gamma2 activation by regulating B cell linker protein-PLC-gamma2 binding. J Exp Med. 2000;191(4):641-650.
10. Kitaura Y, Jang IK, Wang Y, et al. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity. 2007;26(5):567-578. (Pubitemid 46756348)
11. Mankai A, Eveillard JR, Buhe V, et al. Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia? Ann N Y Acad Sci. 2007;1107:193-205. (Pubitemid 47528796)
12. Niiro H, Maeda A, Kurosaki T, Clark EA. The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival. J Exp Med. 2002;195(1): 143-149. (Pubitemid 34074504)
13. Niiro H, Allam A, Stoddart A, Brodsky FM, Marshall AJ, Clark EA. The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor internalization. J Immunol. 2004;173(9):5601-5609. (Pubitemid 39392147)
14. Take H, Watanabe S, Takeda K, Yu ZX, Iwata N, Kajigaya S. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl. Biochem Biophys Res Commun. 2000; 268(2):321-328. (Pubitemid 30119620)
15. Gout I, Middleton G, Adu J, et al. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. EMBO J. 2000;19(15):4015-4025. (Pubitemid 30608540)
16. Bogler O, Furnari FB, Kindler-Roehrborn A, et al. SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes. Neuro Oncol. 2000;2(1):6-15.
17. Narita T, Amano F, Yoshizaki K, et al. Assignment of SH3KBP1 to human chromosome band Xp22.1->21.3 by in situ hybridization. Cytogenet Cell Genet. 2001;93(1-2):133-134. (Pubitemid 32727563)
18. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature. 2002;416(6877):187-190. (Pubitemid 34246477)
19. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature. 2002;416(6877):183-187. (Pubitemid 34246476)
20. Molfetta R, Belleudi F, Peruzzi G, et al. CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. J Immunol. 2005; 175(7):4208-4216. (Pubitemid 41361954)
21. Peruzzi G, Molfetta R, Gasparrini F, et al. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. J Immunol. 2007;179(4):2089-2096.
22. Marois L, Vaillancourt M, Pare G, et al. CIN85 modulates the down-regulation of Fc gammaRIIa expression and function by c-Cbl in a PKCdependent manner in human neutrophils. J Biol Chem. 2011;286(17):15073-15084.
23. Tabrizi SJ, Niiro H, Masui M, et al. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. J Immunol. 2009;182(3):1490-1499.
24. Narita T, Nishimura T, Yoshizaki K, Taniyama T. CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis. Exp Cell Res. 2005;304(1):256-264. (Pubitemid 40222092)
25. Havrylov S, Rzhepetskyy Y, Malinowska A, Drobot L, Redowicz MJ. Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. Proteome Sci. 2009;7:21.
26. Watanabe S, Take H, Takeda K, Yu ZX, Iwata N, Kajigaya S. Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes. Biochem Biophys Res Commun. 2000;278(1):167-174.
27. Chiu CW, Dalton M, Ishiai M, Kurosaki T, Chan AC. BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins. EMBO J. 2002;21(23):6461-6472. (Pubitemid 35448424)
28. Marshall AJ, Niiro H, Yun TJ, Clark EA. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway. Immunol Rev. 2000;176:30-46.
29. Turner M. B-cell development and antigen receptor signalling. Biochem Soc Trans. 2002;30(4): 812-815. (Pubitemid 35001665)
30. Peng SL, Gerth AJ, Ranger AM, Glimcher LH. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity. 2001;14(1):13-20. (Pubitemid 32144683)
31. Rao N, Ghosh AK, Ota S, et al. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 2001;20(24):7085-7095. (Pubitemid 34062300)
32. Sohn HW, Gu H, Pierce SK. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk. J Exp Med. 2003;197(11):1511-1524. (Pubitemid 36682548)
33. Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol. 2002; 168(5):2101-2110. (Pubitemid 34171808)
34. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol. 1998;160(12):5898-5906. (Pubitemid 28298049)
35. Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol. 2003;21:205-230. (Pubitemid 37174531)
36. Turner M, Schweighoffer E, Colucci F, Di Santo JP, Tybulewicz VL. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today. 2000;21(3):148-154. (Pubitemid 30122705)
37. Stamenova SD, French ME, He Y, Francis SA, Kramer ZB, Hicke L. Ubiquitin binds to and regulates a subset of SH3 domains. Mol Cell. 2007; 25(2):273-284. (Pubitemid 46109609)
38. Shimokawa N, Haglund K, Holter SM, et al. CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice. EMBO J. 2010; 29(14):2421-2432.
39. Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, Brodsky FM. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity. 2002;17(4):451-462. (Pubitemid 35223534)
40. Jacob M, Todd L, Sampson MF, Pure E. Dual role of Cbl links critical events in BCR endocytosis. Int Immunol. 2008;20(4):485-497. (Pubitemid 351426043)
41. Zhang M, Veselits M, O'Neill S, et al. Ubiquitinylation of Ig beta dictates the endocytic fate of the B cell antigen receptor. J Immunol. 2007;179(7): 4435-4443.
42. Oellerich T, Bremes V, Neumann K, et al. The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. EMBO J. 2011;30(17):3620-3634.
43. Kometani K, Yamada T, Sasaki Y, et al. CIN85 drives B cell responses by linking BCR signals to the canonical NF-kappaB pathway. J Exp Med. 2011;208(7):1447-1457.
44. Buchse T, Horras N, Lenfert E, et al. CIN85 interacting proteins in B cells-specific role for SHIP-1. Mol Cell Proteomics. 2011;10(10):M110.